A Multicenter Trial of Benefits of Adding Chemotherapy as the Adjuvant Post-surgery Therapy for Cervical Cancer With Adverse Pathological Prognostic Factors
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
distant metastasis free survival,disease free survival
5-Yr
Yes
Jihong Liu, Ph.D.
Study Chair
Sun Yat-sen University
China: Ministry of Health
2008049
NCT00806117
February 2008
December 2017
Name | Location |
---|